Overview
Status
Active
Registry date
2017-09-28
Share capital
5,000.00 PLN
Registered address
ul. Zięby 40/39, 02-808 Warszawa, Poland
Financials
Revenue history (in k)
Filing timeliness
2 of 6 financial statements were filed late (the longest delay 59 days for 2020).
- 202513/07/2026
- 202413/06/2025
- 202327/06/2024
- 202228/06/2023
- 202131/08/2022
- 202013/12/2021
Filed on timeDelayFiling deadline
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2025.
Results vs industry
Revenue
This companyUSD 29.99kMedianUSD 1.06mAverageUSD 22.41m
Net profit
This companyUSD 492.04MedianUSD 37.20kAverageUSD 879.46k
Operating costs
This companyUSD 28.77kMedianUSD 921.66kAverageUSD 21.08m
Assets
This companyUSD 23.96kMedianUSD 609.79kAverageUSD 11.85m
Industry
Authorized Representatives
Katarzyna Patrycja Bem – Attorney-in-fact (sole)
Donato Massimo Laurenza – President of the Management Board
Manner of representation
Each member of the management board is authorized to make declarations on behalf of the company independently.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Katarzyna Patrycja Bemage 53 | 20 | $270.12 | 20% |
Donato Massimo Laurenza | 80 | $1,080.50 | 80% |
Beneficial owners
| Person | Rights |
|---|---|
Bank accounts
Registered as a VAT taxpayer on 2017-10-12.
45 1160 2202 0000 0003 3527 0406
Debt
No entries in the National Debtors Register (KRZ).
Public aid
No public aid cases recorded in the last 10 years.
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Vorwarts Pharmasp. z o.o. | $210,138.62 | vorwartspharma.pl | ||
| Black & Whitesp. z o.o. | $154,866.36 | polonus.pl | ||
| Osteoprofsp. z o.o. | $72,065.80 | osteoprof.pl | ||
| THC PharmaS.A. | $39,093.70 | thc-pharma.pl | ||
| EDGE Pharmasp. z o.o. | $19,855.64 | edgepharma.eu | ||
| Arcade Internationalsp. z o.o. | $17,817.26 | arcade-int.pl | ||
| Filicosp. z o.o. | $11,710.75 | filico.eu | ||
| Get Ready Wheelchairssp. z o.o. | $9,842.54 | getreadywheelchairs.com | ||
| Jacek Waksmundzki Trust 2S.K.A. | $5,769.53 | trust.pl | ||
| Optimedussp. z o.o. | $1.00 | optimedus.pl |
FAQ
The main business activity of BCI focuses on wholesale of pharmaceutical goods.
The company was registered in the Polish National Court Register (KRS) on September 28, 2017.
The headquarters is located at: ul. Zięby 40, 02-808 Warszawa.
The share capital of the company is PLN 5,000 (approx. $1,351).
The latest available financial statement covers the period from January 1, 2024 to December 31, 2024.
In 2024, the company generated total revenue of $38,463, representing an increase of 12.4% compared to 2023.
No, the company recorded a net loss of $7,942 in 2024. For comparison, in 2023 the loss was $2,562, meaning the company increased its loss by 194.4%.
The largest operating cost category falls under employee remuneration. This category amounted to $31,545 in 2024, representing 92% of all operating expenses.
Last updated: 2026-07-16